| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,920 |
17,716 |
$1.20M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,154 |
7,098 |
$687K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,547 |
6,208 |
$594K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
31,308 |
13,579 |
$396K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,232 |
2,228 |
$230K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,799 |
1,722 |
$148K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
691 |
688 |
$77K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,837 |
5,531 |
$75K |
| 99000 |
|
3,717 |
3,630 |
$44K |
| 90461 |
|
7,720 |
6,576 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,414 |
1,376 |
$23K |
| 87428 |
|
324 |
319 |
$22K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
886 |
881 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
352 |
179 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
153 |
153 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
105 |
104 |
$6K |
| 99381 |
|
49 |
48 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
512 |
183 |
$2K |
| 96381 |
|
19 |
19 |
$328.74 |
| 90651 |
|
142 |
141 |
$308.24 |
| 90686 |
|
5,016 |
4,941 |
$307.50 |
| 90473 |
|
15 |
15 |
$141.15 |
| 90677 |
|
911 |
899 |
$93.66 |
| 90633 |
|
1,311 |
1,299 |
$44.75 |
| 94760 |
|
51 |
50 |
$20.51 |
| 90670 |
|
3,661 |
3,495 |
$0.02 |
| 90697 |
|
1,342 |
1,241 |
$0.01 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
266 |
254 |
$0.00 |
| 90707 |
|
103 |
99 |
$0.00 |
| 90710 |
|
52 |
52 |
$0.00 |
| 90734 |
|
28 |
28 |
$0.00 |
| 90698 |
|
1,819 |
1,807 |
$0.00 |
| 90744 |
|
464 |
463 |
$0.00 |
| 90680 |
|
2,160 |
2,055 |
$0.00 |
| 90656 |
|
832 |
831 |
$0.00 |
| 90696 |
|
56 |
56 |
$0.00 |
| 96127 |
|
14 |
14 |
$0.00 |
| 90381 |
|
13 |
13 |
$0.00 |
| 90716 |
|
102 |
102 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
14 |
14 |
$0.00 |
| 36416 |
|
15 |
14 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |